Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%, Aiming to Achieve"RMB10 Billion in Profit"

Rhea-AI Summary

Fosun International (OTC:FOSUF) reported total 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion. Overseas revenue was RMB94.86 billion (54.7%). The Group recorded a RMB23.4 billion book loss from impairments and revaluations.

Fosun invested RMB7.8 billion in technology innovation, secured multiple drug approvals and clinical starts, held RMB61.1 billion cash, and set medium-term targets including restoring annual profit to ~RMB10 billion.

Positive

• Total revenue of RMB173.43 billion in 2025
• Overseas revenue RMB94.86 billion (54.7% of total)
• Adjusted industrial operation profit of RMB4 billion
• Fosun Pharma net profit RMB3.371 billion (+21.69% YoY)
• Tech investment RMB7.8 billion and 16 indications approved

Negative

• Book loss from impairments and revaluations RMB23.4 billion
• Real estate-related impairment ~55% of total impairments
• Total debt to total capital ratio at 57%

Market Context

This announcement outlines Fosun’s 2025 performance, highlighting total revenue of RMB173.43 billion...

Analysis

This announcement outlines Fosun’s 2025 performance, highlighting total revenue of RMB173.43 billion, profit growth at core subsidiaries, and overseas revenue of RMB94.86 billion (54.7% of total). It also discloses a RMB23.4 billion book loss from non-cash impairments and sets medium-term goals to restore profit to around RMB10 billion and lower group-level debt. Investors may watch progress on cash recovery, debt reduction, and delivery on the higher dividend payout target for 2026 and beyond.

Key Figures

Total revenue: RMB173.43 billion Adj. industrial profit: RMB4 billion Core subsidiaries revenue: RMB128.2 billion +5 more

8 metrics

Total revenue RMB173.43 billion Group revenue for 12 months ended 31 Dec 2025

Adj. industrial profit RMB4 billion Adjusted industrial operation profit in 2025

Core subsidiaries revenue RMB128.2 billion Revenue from four core subsidiaries, 74% of total

Fosun Pharma net profit RMB3.371 billion Net profit attributable to shareholders, up 21.69% YoY

Fosun Insurance Portugal profit EUR201 million Net profit attributable to owners, up 15.8% YoY

Overseas revenue RMB94.86 billion Accounts for 54.7% of total revenue; mix up 5.4 pts YoY

Book loss from impairments RMB23.4 billion Non-cash impairments and revaluations in 2025

Debt to capital ratio 57% Total debt to total capital at end of Reporting Period

Historical Context

5 past events · Latest: Feb 26 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 26	ESG reporting award	Positive	+2.0%	Recognition for ESG reporting and sustainability-linked financing initiatives.
Jan 21	ESG index inclusion	Positive	-17.2%	Improved FTSE Russell ESG score and continued FTSE4Good inclusion.
Dec 21	ESG awards	Positive	-11.5%	Multiple ESG accolades and disclosures on healthcare and insurance reach.
Nov 20	ESG leadership award	Positive	-12.5%	Named ESG Leading Enterprise with strong ratings and social impact metrics.
Nov 06	Sustainability awards	Positive	-1.1%	Gold sustainability award and reiteration of carbon and ESG commitments.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent ESG-related positive news often coincided with negative price reactions, suggesting a pattern where upbeat non-financial announcements did not consistently support the share price.

Recent Company History

Over the past few months, Fosun’s news flow has centered on ESG recognition and sustainability credentials, including multiple awards and improved ESG scores between Nov 2025 and Feb 2026. Despite these positive reputational developments, several announcements saw negative next-day price reactions. Compared with those ESG-focused items, the current release adds concrete financial metrics, profitability at core subsidiaries, and capital structure targets, marking a shift from primarily reputational milestones to operational and balance sheet detail.

Key Terms

non-cash impairment provisions, dividend payout ratio, investment-grade rating

3 terms

non-cash impairment provisions financial

"pursuant to the principle of prudence, Fosun made non-cash impairment provisions"

Non-cash impairment provisions are accounting charges that reduce the recorded value of assets when their recoverable worth falls below their book value; no cash changes hands, but the write-down is recorded as an expense. Think of it like marking down the price of an old appliance because it’s worth less than you thought—this lowers reported profits and shareholders’ equity, so investors watch these charges to assess true asset health and future earnings quality.

dividend payout ratio financial

"plans to increase its target dividend payout ratio for the 2026 financial year"

The dividend payout ratio is the share of a company’s net profit that is returned to shareholders as cash dividends rather than kept for reinvestment. Investors use it to judge whether dividend payments are likely sustainable and how the company balances rewarding owners with funding growth; a high ratio is like handing most of your paycheck to friends now, while a low ratio is like saving more for future expenses and opportunities.

investment-grade rating financial

"and work to achieve an "investment-grade" rating."

An investment-grade rating is a credit score assigned by a rating agency that signals a borrower—such as a company or government—is considered low risk of failing to pay its debts. For investors, this is like a product safety label or a person’s good credit score: it typically means lower chance of losing principal, steadier interest payments, and cheaper borrowing costs for the issuer, so these securities are often used in conservative portfolios.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG, March 30, 2026 /PRNewswire/ -- On 30 March, Fosun International (00656.HK) announced its results for the 12 months ended 31 December 2025. In 2025, Fosun's fundamentals remained solid, core industries such as pharmaceuticals and healthcare and insurance and finance demonstrated a good development trend, and the twin drivers of innovation and globalization delivered strong momentum.

During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit amounted to RMB4 billion. The four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma, a core subsidiary in the Health segment, achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%; Fosun Insurance Portugal, a core subsidiary in the Wealth segment, reported a net profit attributable to owners of the parent of EUR201 million, up 15.8% year on year.

During the Reporting Period, the Group's investment in technology innovation reached RMB7.8 billion, and 16 indications of 7 innovative drugs were approved for marketing in China and overseas markets. In addition, nearly 40 innovative drug clinical trials were approved by regulatory authorities in China, the United States and Europe, while multiple core products entered key clinical phases, laying a solid pipeline foundation for subsequent commercial growth.

During the Reporting Period, the Group's overseas revenue reached RMB94.86 billion, accounting for 54.7% of total revenue, representing a year-on-year increase of 5.4 percentage points. For innovative drugs, total upfront payments from licensing-out and co-development for the year exceeded USD260 million, with total potential milestone payments exceeding USD4 billion. Club Med once again achieved record-high performance, while insurance companies in China and overseas delivered broad-based growth.

Fosun has continued to advance its strategy of "streamlining operations and strengthening the business, focusing on core businesses". During the Reporting Period, pursuant to the principle of prudence, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of RMB23.4 billion for the year, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%. These provisions do not affect the Company's overall operations and cash flow.

In his letter to shareholders, Guo Guangchang, Chairman of Fosun International, stated: "Some of the projects we invested in years ago are now indeed valued differently under current market conditions from what we expected at the time of investment. Accordingly, the Board has prudently chosen to complete this asset impairment, allowing Fosun to better concentrate its resources and efforts on high-growth core sectors. As the global economy presents opportunities amid fluctuations and China's innovation industry gains momentum, deepening our strategic focus now allows us not only to optimize our asset structure, but also to seize industry opportunities, positioning Fosun as a leaner, healthier, and more sustainable company."

At the same time, Fosun has maintained a healthy financial position, with ample cash reserves, a solid net asset base, and positive net cash inflow from operating activities. As at the end of the Reporting Period, total debt to total capital ratio was 57%; in addition to cash, bank balances and term deposits of RMB61.1 billion, unutilized banking facilities amounted to RMB144.6 billion. A healthy debt ratio and ample funds not only strengthen the Company's risk resilience, but also enhance its capacity to seize opportunities. International rating agency S&P has affirmed the outlook for Fosun International's credit rating as "Stable".

"It is precisely this strong foundation, together with the continued support of our partners, that gives us the confidence and determination to 'repair the roof while the sun is shining' — to shed burdens at this stage and pursue predictable, sustainable growth for the future. We must strengthen our core businesses with greater focus and depth. This is the path for Fosun to move more steadily and go further in the next phase," said Guo Guangchang.

Fosun also announced its medium-term financial targets: to strive to gradually restore annual profit to around RMB10 billion; to target the recovery of RMB60 billion in cash at the Group level, reduce total Group-level debt to below RMB60 billion, and work to achieve an "investment-grade" rating.

In terms of further enhancing shareholder returns, in addition to share purchases by the controlling shareholder and management, as well as the Company's continued share buybacks, Fosun announced that it plans to increase its target dividend payout ratio for the 2026 financial year from the current 20% to 35%, and is committed to further raising the payout ratio over time. Based on the Company's accumulated distributable profits, dividends for the 2026 financial year are expected to be no less than HKD1.5 billion.

"For the future, Fosun will not pursue short-term gains; instead, we will build a solid foundation for enduring growth," said Guo Guangchang.

View original content:https://www.prnewswire.com/news-releases/fosun-international-total-revenue-in-2025-reaches-rmb173-43-billion-with-overseas-revenue-accounting-for-54-7-aiming-to-achievermb10-billion-in-profit-302728815.html

SOURCE Fosun

FAQ

What were Fosun International (FOSUF) key 2025 revenue and profit figures?

Fosun reported RMB173.43 billion revenue and adjusted industrial operation profit of RMB4 billion. According to Fosun International, the Group's overseas revenue reached RMB94.86 billion, representing 54.7% of total revenue.

Why did Fosun International record a RMB23.4 billion book loss in 2025 (FOSUF)?

The book loss mainly resulted from non-cash impairments and revaluations across assets. According to Fosun International, impairments covered certain real estate projects and goodwill in non-core segments, with real estate accounting for about 55% of the total provision.

What medium-term financial targets did Fosun International (FOSUF) announce?

Fosun aims to restore annual profit to around RMB10 billion and cut group-level debt below RMB60 billion. According to Fosun International, the company also targets RMB60 billion cash recovery and an investment-grade rating.

How strong is Fosun International's cash and liquidity position after 2025 results (FOSUF)?

Fosun held RMB61.1 billion in cash, bank balances and term deposits plus RMB144.6 billion unutilized facilities. According to Fosun International, these resources support risk resilience and capacity to pursue opportunities.

What shareholder return changes did Fosun International (FOSUF) propose for 2026 dividends?

Fosun plans to raise its target dividend payout ratio to 35% for the 2026 financial year and expects dividends of at least HKD1.5 billion. According to Fosun International, the company intends to further increase the payout ratio over time.